Central nervous system lymphoma associated with natalizumab
Angelika Na, Nick Hall, Bhadrakant Kavar, John King
Journal of Clinical Neuroscience | ELSEVIER SCI LTD | Published : 2014
Patients with primary central nervous system lymphoma (PCNSL) after treatment with natalizumab have been considered co-incidental. We report another case of PCNSL in a patient where the explosive onset suggests a causal link.